全文获取类型
收费全文 | 7439篇 |
免费 | 510篇 |
国内免费 | 120篇 |
专业分类
耳鼻咽喉 | 69篇 |
儿科学 | 127篇 |
妇产科学 | 132篇 |
基础医学 | 987篇 |
口腔科学 | 219篇 |
临床医学 | 603篇 |
内科学 | 1471篇 |
皮肤病学 | 243篇 |
神经病学 | 592篇 |
特种医学 | 256篇 |
外科学 | 902篇 |
综合类 | 303篇 |
预防医学 | 584篇 |
眼科学 | 169篇 |
药学 | 678篇 |
2篇 | |
中国医学 | 119篇 |
肿瘤学 | 613篇 |
出版年
2023年 | 47篇 |
2022年 | 157篇 |
2021年 | 225篇 |
2020年 | 127篇 |
2019年 | 175篇 |
2018年 | 206篇 |
2017年 | 202篇 |
2016年 | 256篇 |
2015年 | 250篇 |
2014年 | 350篇 |
2013年 | 374篇 |
2012年 | 570篇 |
2011年 | 562篇 |
2010年 | 299篇 |
2009年 | 257篇 |
2008年 | 410篇 |
2007年 | 406篇 |
2006年 | 388篇 |
2005年 | 426篇 |
2004年 | 339篇 |
2003年 | 282篇 |
2002年 | 271篇 |
2001年 | 190篇 |
2000年 | 152篇 |
1999年 | 121篇 |
1998年 | 42篇 |
1997年 | 43篇 |
1996年 | 37篇 |
1995年 | 34篇 |
1994年 | 33篇 |
1993年 | 26篇 |
1992年 | 63篇 |
1991年 | 54篇 |
1990年 | 52篇 |
1989年 | 55篇 |
1988年 | 58篇 |
1987年 | 47篇 |
1986年 | 43篇 |
1985年 | 46篇 |
1984年 | 26篇 |
1983年 | 22篇 |
1980年 | 17篇 |
1979年 | 25篇 |
1977年 | 21篇 |
1976年 | 21篇 |
1975年 | 17篇 |
1972年 | 26篇 |
1970年 | 22篇 |
1969年 | 22篇 |
1967年 | 18篇 |
排序方式: 共有8069条查询结果,搜索用时 15 毫秒
1.
Anders Elm Pedersen Esben Gjerløff Wedebye Schmidt Jesper Freddie Sørensen Carsten Faber Boye Schnack Nielsen Kim Holmstrøm Silje Haukali Omland Peter Tougaard Søren Skov Bo Bang 《APMIS : acta pathologica, microbiologica, et immunologica Scandinavica》2015,123(7):547-555
TL1A is a TNF‐like cytokine which has been shown to co‐stimulate TH1 and TH17 responses during chronic inflammation. The expression of this novel cytokine has been investigated in inflammatory disorders like rheumatoid arthritis and inflammatory bowel disease, but little is known about expression and induction in psoriasis. Indeed, the pathogenesis in psoriasis is still not fully understood and it is speculated that cytokines other than TNF‐α are important in subsets of patients. Also, for patients with severe disease that are treated with systemic anti‐TNF‐α blockade, novel candidates to be used as disease and response biomarkers are of high interest. Here, we demonstrate TL1A expression in biopsies from psoriatic lesions. Also, we investigated spontaneous and induced TL1A secretion from PBMCs and blood levels from a cohort of psoriasis patients. Here, increased spontaneous secretion from PBMCs was observed as compared to healthy controls and a small subset of patients had highly elevated TL1A in the blood. Interestingly, activation of PBMCs with various cytokines showed a decreased sensitivity for TL1A activation in psoriasis patients compared to healthy controls.TL1A levels in blood and biopsies could not be correlated with disease activity with this patient cohort. Thus, additional large‐scale studies are warranted to investigate TL1A as a biomarker. 相似文献
2.
3.
4.
J. Saßmannshausen N. Bornfeld A. Kluge W. Sauerwein F. Härting A. Wessing 《International ophthalmology》1989,13(4):243-251
Advanced malignant melanomas of the uvea unsuited for an eye salvaging approach require enucleation of the tumor containing eye. A series of 68 patients is reported who underwent enucleation combined with insertion of a spherical dura-encased implant after 30 Gray pre-irridiation therapy of the orbit. Postoperative results with special attention to cosmetic outcome and motility of the prosthesis suggest that the insertion of an orbital implant should be preferred to the enucleation with no implant. 相似文献
5.
Frank Lindseth Thomas Lang? Jon Bang Toril A Nagelhus Hernes 《Computer aided surgery》2002,7(4):197-222
6.
7.
Choe Seong Wook MD Cho Wan Ik MD Lee Chang Kyun MD † Seo Seong Jun MD 《Dermatologic surgery》2005,31(5):502-508
BACKGROUND: Masseteric muscle hypertrophy is an uncommon dition represented as a swelling of the masseter muscle. Recent reports have demonstrated the successful use of botulinum in the treatment of masseteric hypertrophy. OBJECTIVE: This study was a prospective trial to evaluate the effectiveness of botulinum toxin type A (Botox) in the treatment of masseteric muscle hypertrophy according to doses of 10, 20, and 30 U. MATERIALS AND METHODS: Twenty-two patients were referred to the dermatologic clinic for the management of masseteric muscle hypertrophy. Ultrasonographic measurements of the thickness of the masseter muscle were performed, and clinical photographs were taken before treatment and 1, 2, 3, 4, 6, and 9 months after the treatment. RESULTS. The median values of percentage reduction of muscle mass were 10.3%, 16.5%, 23.7%, 24.7%, 21.6%, 16.5% in the 10 U group; 11.9%, 18.8%, 24.8%, 27.7%, 26.7%, and 21.8% in the 20 U group; and 12.0%, 19.4%, 25.0%, 27.8%, 37.8%, and 24.1% in the 30 U group. CONCLUSION. The adequate dose of botulinum toxin type A for treatment of masseteric muscle hypertrophy should be above 20 U. The effect of botulinum toxin type A is maintained for at least 9 months as the treatment of masseteric muscle hypertrophy. 相似文献
8.
Vectorization of morpholino oligomers by the (R-Ahx-R)4 peptide allows efficient splicing correction in the absence of endosomolytic agents. 总被引:1,自引:0,他引:1
Sa?d Abes Hong M Moulton Philippe Clair Paul Prevot Derek S Youngblood Rebecca P Wu Patrick L Iversen Bernard Lebleu 《Journal of controlled release》2006,116(3):304-313
The efficient and non-toxic nuclear delivery of steric-block oligonucleotides (ON) is a prerequisite for therapeutic strategies involving splice correction or exon skipping. Cationic cell penetrating peptides (CPPs) have given rise to much interest for the intracellular delivery of biomolecules, but their efficiency in promoting cytoplasmic or nuclear delivery of oligonucleotides has been hampered by endocytic sequestration and subsequent degradation of most internalized material in endocytic compartments. In the present study, we compared the splice correction activity of three different CPPs conjugated to PMO(705), a steric-block ON targeted against the mutated splicing site of human beta-globin pre-mRNA in the HeLa pLuc705 splice correction model. In contrast to Tat48-60 (Tat) and oligoarginine (R(9)F(2)) PMO(705) conjugates, the 6-aminohexanoic-spaced oligoarginine (R-Ahx-R)(4)-PMO(705) conjugate was able to promote an efficient splice correction in the absence of endosomolytic agents. Our mechanistic investigations about its uptake mechanisms lead to the conclusion that these three vectors are internalized using the same endocytic route involving proteoglycans, but that the (R-Ahx-R)(4)-PMO(705) conjugate has the unique ability to escape from lysosomial fate and to access to the nuclear compartment. This vector, which has displays an extremely low cytotoxicity, the ability to function without chloroquine adjunction and in the presence of serum proteins. It thus offers a promising lead for the development of vectors able to enhance the delivery of therapeutic steric-block ON in clinically relevant models. 相似文献
9.
10.
应用聚合酶链反应 限制性片段长度多态性技术 (PCR RFLP) ,以北京自然人群为基础 ,采用分层随机抽样的方法进行横断面研究 ,对 1 0 46人进行apoE基因分型 ,并分析不同特点人群apoE基因频率分布特点。结果表明 :1 )本组人群ε2、ε3、ε4基因频率分别为 9.1 %、81 .2 %和 9.7% ,男女和各年龄组间基因频率无显著差异 ;2 )与欧美国家相比 ,本组人群ε2基因频率增高 ,ε4频率减低 ,与日本人群相比也有相同趋势 ;3 )在空腹血糖受损及糖尿病人群中ε2频率明显增高 ;4)在高胆固醇血症人群中ε2频率减低、ε4基因频率增高 相似文献